Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

News

Recent News

Defense Stocks Look Bulletproof, But The Bill Could Hit 2.6% Of GDP
Defense Stocks Look Bulletproof, But The Bill Could Hit 2.6% Of GDP
Defense stocks look bulletproof as military budgets rise, but widening deficits, higher debt and stubborn rates could turn the rearmament boom into a trap.
X-Energy Stock Opens 31% Above IPO Price As Amazon-Backed Nuclear Play Hits Nasdaq
X-Energy Stock Opens 31% Above IPO Price As Amazon-Backed Nuclear Play Hits Nasdaq
X-Energy stock made its Nasdaq debut Friday after the nuclear company raised more than $1 billion in an upsized initial public offering.
The Chip Stock Rally That Broke History: SOXX Notches Record 17-Day Win Streak
The Chip Stock Rally That Broke History: SOXX Notches Record 17-Day Win Streak
The Philadelphia Semiconductor Index has logged 17 consecutive green trading sessions, sending ETFs like SOXX, SOXL and SMH flying.
Why SanDisk Stock Is Breaking Out To New All-Time Highs Today
Why SanDisk Stock Is Breaking Out To New All-Time Highs Today
SanDisk Corp (NASDAQ:SNDK) shares surged Friday afternoon to a new all-time high, as risk-on momentum lifted tech and semis.
Deal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11
Deal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11
Major M&A deals this week include Eli Lilly buys Kelonia for $7 billion, Honeywell sells PSS to Brady Corp., KSL buys Invited Clubs.
Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%
Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%
Daniel Loeb trims major stake in Kenvue as company advances restructuring and prepares for acquisition by Kimberly-Clark.
What's Going On With Enveric Biosciences Stock On Friday?
What's Going On With Enveric Biosciences Stock On Friday?
The FDA issues priority vouchers and clears early trials for ibogaine derivatives for using psychedelics for therapy and mental health.
These Analysts Increase Their Forecasts On Keurig Dr Pepper After Better-Than-Expected Q1 Results
These Analysts Increase Their Forecasts On Keurig Dr Pepper After Better-Than-Expected Q1 Results
Keurig Dr Pepper (NASDAQ:KDP) reported better-than-expected Q1 earnings and affirmed its sales outlook. Analysts raised price targets for KDP stock.
Southwest Airlines Analysts Boost Their Forecasts Following Q1 Earnings
Southwest Airlines Analysts Boost Their Forecasts Following Q1 Earnings
Southwest Airlines (NYSE: LUV) reported disappointing Q1 results and lowered its Q2 guidance, causing analysts to adjust their price targets.
Union Pacific Analysts Increase Their Forecasts Following Upbeat Q1 Earnings
Union Pacific Analysts Increase Their Forecasts Following Upbeat Q1 Earnings
Union Pacific reported better-than-expected Q1 earnings, with a 3% increase in operating revenue and reaffirmed its 2026 outlook.
These Analysts Revise Their Forecasts On Boyd Gaming After Q1 Results
These Analysts Revise Their Forecasts On Boyd Gaming After Q1 Results
Boyd Gaming (BYD) reported worse-than-expected Q1 results and announced a $500 million buyback plan. Analysts lowered price targets.
These Analysts Increase Their Forecasts On Churchill Downs After Upbeat Q1 Results
These Analysts Increase Their Forecasts On Churchill Downs After Upbeat Q1 Results
Churchill Downs Inc (NASDAQ:CHDN) reported better-than-expected earnings and saw a 3.2% increase in stock price. Analysts have raised price targets.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved